CGAS and glioblastoma: The cGAS-STING Signalling Pathway was significantly enriched in gartisertib (−log10 (B-H p-value) = 2.85, z-score = 4.81) and gartisertib+TMZ+RT (−log10 (B-H p-value) = 4.45, z-score = 5.47) treated groups after IPA analysis across the 12 glioblastoma cell lines.